nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Pain—Ifosfamide—testicular cancer	0.00133	0.00133	CcSEcCtD
Linezolid—Constipation—Ifosfamide—testicular cancer	0.00133	0.00133	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Linezolid—Cough—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Linezolid—Thrombocytopenia—Cisplatin—testicular cancer	0.00131	0.00131	CcSEcCtD
Linezolid—Asthenia—Bleomycin—testicular cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Convulsion—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Skin disorder—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Hypertension—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Linezolid—Hyperhidrosis—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Linezolid—Liver function test abnormal—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Linezolid—Pruritus—Bleomycin—testicular cancer	0.00128	0.00128	CcSEcCtD
Linezolid—Eosinophilia—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Linezolid—Nausea—Vinblastine—testicular cancer	0.00128	0.00128	CcSEcCtD
Linezolid—Anorexia—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Linezolid—Hypokalaemia—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Linezolid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Linezolid—Pancreatitis—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Linezolid—Gastritis—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Urticaria—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Body temperature increased—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Abdominal pain—Ifosfamide—testicular cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Anaphylactic shock—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Linezolid—Asthenia—Dactinomycin—testicular cancer	0.00121	0.00121	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Linezolid—Paraesthesia—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Linezolid—Thrombocytopenia—Etoposide—testicular cancer	0.0012	0.0012	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Linezolid—Eosinophilia—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Linezolid—Dyspnoea—Cisplatin—testicular cancer	0.00119	0.00119	CcSEcCtD
Linezolid—Skin disorder—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Linezolid—Hyperhidrosis—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Linezolid—Pancreatitis—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Linezolid—Anorexia—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Decreased appetite—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Diarrhoea—Dactinomycin—testicular cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00115	0.00115	CcSEcCtD
Linezolid—Vomiting—Bleomycin—testicular cancer	0.00115	0.00115	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Linezolid—Rash—Bleomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Pain—Cisplatin—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Dermatitis—Bleomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Linezolid—Renal failure—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Linezolid—Neutropenia—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Linezolid—Stomatitis—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Linezolid—Asthenia—Ifosfamide—testicular cancer	0.00111	0.00111	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Linezolid—Pruritus—Ifosfamide—testicular cancer	0.0011	0.0011	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Linezolid—Dyspnoea—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Linezolid—Somnolence—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Nausea—Bleomycin—testicular cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Vomiting—Dactinomycin—testicular cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Linezolid—Rash—Dactinomycin—testicular cancer	0.00107	0.00107	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Diarrhoea—Ifosfamide—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Renal failure—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Body temperature increased—Cisplatin—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Fatigue—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Linezolid—Pain—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Linezolid—Constipation—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Linezolid—Dizziness—Ifosfamide—testicular cancer	0.00103	0.00103	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Linezolid—Nausea—Dactinomycin—testicular cancer	0.00101	0.00101	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Linezolid—Vomiting—Ifosfamide—testicular cancer	0.000986	0.000986	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—testicular cancer	0.000979	0.000979	CcSEcCtD
Linezolid—Rash—Ifosfamide—testicular cancer	0.000978	0.000978	CcSEcCtD
Linezolid—Dermatitis—Ifosfamide—testicular cancer	0.000977	0.000977	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000976	0.000976	CcSEcCtD
Linezolid—Urticaria—Etoposide—testicular cancer	0.000973	0.000973	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—testicular cancer	0.000971	0.000971	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—testicular cancer	0.000971	0.000971	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—testicular cancer	0.000968	0.000968	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—testicular cancer	0.000968	0.000968	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—testicular cancer	0.000963	0.000963	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—testicular cancer	0.000962	0.000962	CcSEcCtD
Linezolid—Asthenia—Cisplatin—testicular cancer	0.000959	0.000959	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Linezolid—Chills—Methotrexate—testicular cancer	0.000927	0.000927	CcSEcCtD
Linezolid—Nausea—Ifosfamide—testicular cancer	0.000921	0.000921	CcSEcCtD
Linezolid—Diarrhoea—Cisplatin—testicular cancer	0.000915	0.000915	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—testicular cancer	0.000901	0.000901	CcSEcCtD
Linezolid—Erythema—Methotrexate—testicular cancer	0.000899	0.000899	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—testicular cancer	0.000899	0.000899	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—testicular cancer	0.000894	0.000894	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—testicular cancer	0.00089	0.00089	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—testicular cancer	0.000888	0.000888	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—testicular cancer	0.00088	0.00088	CcSEcCtD
Linezolid—Asthenia—Etoposide—testicular cancer	0.000879	0.000879	CcSEcCtD
Linezolid—Chills—Epirubicin—testicular cancer	0.000867	0.000867	CcSEcCtD
Linezolid—Pruritus—Etoposide—testicular cancer	0.000867	0.000867	CcSEcCtD
Linezolid—Vomiting—Cisplatin—testicular cancer	0.00085	0.00085	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Linezolid—Rash—Cisplatin—testicular cancer	0.000843	0.000843	CcSEcCtD
Linezolid—Dermatitis—Cisplatin—testicular cancer	0.000842	0.000842	CcSEcCtD
Linezolid—Erythema—Epirubicin—testicular cancer	0.000841	0.000841	CcSEcCtD
Linezolid—Diarrhoea—Etoposide—testicular cancer	0.000838	0.000838	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Linezolid—Anaemia—Methotrexate—testicular cancer	0.000831	0.000831	CcSEcCtD
Linezolid—Flatulence—Epirubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—testicular cancer	0.000824	0.000824	CcSEcCtD
Linezolid—Dizziness—Etoposide—testicular cancer	0.00081	0.00081	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Linezolid—Vertigo—Methotrexate—testicular cancer	0.000808	0.000808	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—testicular cancer	0.000805	0.000805	CcSEcCtD
Linezolid—Chills—Doxorubicin—testicular cancer	0.000802	0.000802	CcSEcCtD
Linezolid—Nausea—Cisplatin—testicular cancer	0.000794	0.000794	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Linezolid—Cough—Methotrexate—testicular cancer	0.000784	0.000784	CcSEcCtD
Linezolid—Convulsion—Methotrexate—testicular cancer	0.000779	0.000779	CcSEcCtD
Linezolid—Vomiting—Etoposide—testicular cancer	0.000779	0.000779	CcSEcCtD
Linezolid—Erythema—Doxorubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Linezolid—Anaemia—Epirubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Linezolid—Rash—Etoposide—testicular cancer	0.000772	0.000772	CcSEcCtD
Linezolid—Dermatitis—Etoposide—testicular cancer	0.000772	0.000772	CcSEcCtD
Linezolid—Headache—Etoposide—testicular cancer	0.000767	0.000767	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—testicular cancer	0.000767	0.000767	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Linezolid—Vertigo—Epirubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Linezolid—Cough—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—testicular cancer	0.000734	0.000734	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Linezolid—Convulsion—Epirubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Linezolid—Nausea—Etoposide—testicular cancer	0.000728	0.000728	CcSEcCtD
Linezolid—Hypertension—Epirubicin—testicular cancer	0.000726	0.000726	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—testicular cancer	0.000718	0.000718	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—testicular cancer	0.000713	0.000713	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Linezolid—Anorexia—Methotrexate—testicular cancer	0.000699	0.000699	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Linezolid—Cough—Doxorubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—testicular cancer	0.000672	0.000672	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—testicular cancer	0.000672	0.000672	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Linezolid—Insomnia—Methotrexate—testicular cancer	0.000664	0.000664	CcSEcCtD
Linezolid—Paraesthesia—Methotrexate—testicular cancer	0.000659	0.000659	CcSEcCtD
Linezolid—Anorexia—Epirubicin—testicular cancer	0.000654	0.000654	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—testicular cancer	0.000654	0.000654	CcSEcCtD
Linezolid—Somnolence—Methotrexate—testicular cancer	0.000652	0.000652	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—testicular cancer	0.000648	0.000648	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—testicular cancer	0.000646	0.000646	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000633	0.000633	CcSEcCtD
Linezolid—Fatigue—Methotrexate—testicular cancer	0.000633	0.000633	CcSEcCtD
Linezolid—Pain—Methotrexate—testicular cancer	0.000627	0.000627	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Linezolid—Insomnia—Epirubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—testicular cancer	0.000617	0.000617	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—testicular cancer	0.000617	0.000617	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Linezolid—Somnolence—Epirubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Linezolid—Gastrointestinal pain—Methotrexate—testicular cancer	0.0006	0.0006	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Linezolid—Fatigue—Epirubicin—testicular cancer	0.000592	0.000592	CcSEcCtD
Linezolid—Constipation—Epirubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Linezolid—Pain—Epirubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Linezolid—Urticaria—Methotrexate—testicular cancer	0.000583	0.000583	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—testicular cancer	0.00058	0.00058	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—testicular cancer	0.00058	0.00058	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—testicular cancer	0.000575	0.000575	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Linezolid—Urticaria—Epirubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Linezolid—Constipation—Doxorubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Linezolid—Pain—Doxorubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Linezolid—Asthenia—Methotrexate—testicular cancer	0.000526	0.000526	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Linezolid—Pruritus—Methotrexate—testicular cancer	0.000519	0.000519	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—testicular cancer	0.000502	0.000502	CcSEcCtD
Linezolid—Asthenia—Epirubicin—testicular cancer	0.000493	0.000493	CcSEcCtD
Linezolid—Pruritus—Epirubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Linezolid—Dizziness—Methotrexate—testicular cancer	0.000485	0.000485	CcSEcCtD
Linezolid—Diarrhoea—Epirubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Linezolid—Vomiting—Methotrexate—testicular cancer	0.000466	0.000466	CcSEcCtD
Linezolid—Rash—Methotrexate—testicular cancer	0.000463	0.000463	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Linezolid—Headache—Methotrexate—testicular cancer	0.00046	0.00046	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Linezolid—Dizziness—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Linezolid—Vomiting—Epirubicin—testicular cancer	0.000437	0.000437	CcSEcCtD
Linezolid—Nausea—Methotrexate—testicular cancer	0.000436	0.000436	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Linezolid—Rash—Epirubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Linezolid—Headache—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Linezolid—Nausea—Epirubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—testicular cancer	0.000404	0.000404	CcSEcCtD
Linezolid—Rash—Doxorubicin—testicular cancer	0.000401	0.000401	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Linezolid—Headache—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Linezolid—Nausea—Doxorubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
